Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Getz

Showing results (231-240 of 397) with videos related to

Pageof 40
Sort By:
Blood Advances|July 28, 2023
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemiaCharlotte Syrykh, Berta Pons-Brun, Núria Russiñol, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
Assessing the significance of chromosomal aberrations in cancer: methodology and application to gliomaRameen Beroukhim, Gad Getz, Leia Nghiemphu, et al.
Nature|October 16, 2015
Mutations driving CLL and their evolution in progression and relapseDan A Landau, Eugen Tausch, Amaro N Taylor-Weiner, et al.
Nature Communications|March 12, 2015
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancerMatthew J Niederst, Lecia V Sequist, John T Poirier, et al.
Nature Genetics|June 28, 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasisWilliam J Gibson, Erling A Hoivik, Mari K Halle, et al.
Cancer Discovery|July 20, 2016
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung CancerJustin F Gainor, Leila Dardaei, Satoshi Yoda, et al.
Nature Medicine|February 2, 2016
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibitionAaron N Hata, Matthew J Niederst, Hannah L Archibald, et al.
Cancer Cell|August 15, 2018
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell CarcinomaRaj K Gopal, Kirsten Kübler, Sarah E Calvo, et al.
Science (New York, N.Y.)|August 3, 2023
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancersRuben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Cell|June 19, 2018
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome SequencingSrinivas R Viswanathan, Gavin Ha, Andreas M Hoff, et al.
Pageof 40

Showing results (231-240 of 397) with videos related to

Sort By:
Pageof 40
Blood Advances|July 28, 2023
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemiaCharlotte Syrykh, Berta Pons-Brun, Núria Russiñol, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
Assessing the significance of chromosomal aberrations in cancer: methodology and application to gliomaRameen Beroukhim, Gad Getz, Leia Nghiemphu, et al.
Nature|October 16, 2015
Mutations driving CLL and their evolution in progression and relapseDan A Landau, Eugen Tausch, Amaro N Taylor-Weiner, et al.
Nature Communications|March 12, 2015
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancerMatthew J Niederst, Lecia V Sequist, John T Poirier, et al.
Nature Genetics|June 28, 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasisWilliam J Gibson, Erling A Hoivik, Mari K Halle, et al.
Cancer Discovery|July 20, 2016
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung CancerJustin F Gainor, Leila Dardaei, Satoshi Yoda, et al.
Nature Medicine|February 2, 2016
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibitionAaron N Hata, Matthew J Niederst, Hannah L Archibald, et al.
Cancer Cell|August 15, 2018
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell CarcinomaRaj K Gopal, Kirsten Kübler, Sarah E Calvo, et al.
Science (New York, N.Y.)|August 3, 2023
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancersRuben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Cell|June 19, 2018
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome SequencingSrinivas R Viswanathan, Gavin Ha, Andreas M Hoff, et al.
Pageof 40